Over the last decade, exciting changes have transformed the pharmaceutical industry. For example, scientific advancements, particularly those that have contributed to the rise in biologics, are increasing the complexity of patient treatments and pharmaceutical products. In addition, many manufacturers are expanding their global footprints to address unmet patient needs in smaller populations across the world.
As drug manufacturers continue to advance medicine with new discoveries in technology and science, the dominance of biologics is expected to continue, with experts predicting them to comprise more than a quarter of the pharmaceutical market by 2020.
In a critical care emergency, fast response and safe administration of blood can be the difference between life and death. Overcoming logistical issues such as how to control shelf life, how to maintain a suitable thermal environment for blood storage and transport, how to determine which patients need pre-hospital blood and what blood products to use in the pre-hospital environment are among the challenges.
It is the goal of this research to identify current packaging options that limit this environmental impact.
Managing the Challenges of Controlled Room Temperature Requirements in Cold Chain Pharmaceutical Distribution
WITH THE EVER EVOLVING DEVELOPMENTS IN THE BIOPHARMACEUTICAL INDUSTRY THERE HAS NEVER BEEN A GREATER NEED FOR ASSURED RELIABILITY WHEN IT COMES TO THE TRANSPORTATION OF PHARMACEUTICAL PAYLOADS AND THE GUARANTEED ROBUSTNESS OF TEMPERATURE-CONTROLLED PACKAGING IS PROVING EVER MORE VITAL. Read more....
Reusable Crēdo Cube™ reduces global warming potential by 75 percent and post-consumer waste by 95 percent.